This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2018-08-01 FMG concall"
Jump to navigation
Jump to search
(→Agenda) |
|||
Line 41: | Line 41: | ||
**Anne to nudge TSC about what they want to do about expiring FMG positions | **Anne to nudge TSC about what they want to do about expiring FMG positions | ||
***TSC referred to SGB | ***TSC referred to SGB | ||
+ | **documenting/communicating policy on balloting/publishing as Normative (FMM5) | ||
+ | **Vetting unapproved resources for publication | ||
*Review Items | *Review Items | ||
**[https://gforge.hl7.org/gf/download/trackeritem/17579/16735/PDDI%20CDS%20PSS%2002-15-2018%201.docx Contextualized potential drug-drug interaction clinical decision support PSS] | **[https://gforge.hl7.org/gf/download/trackeritem/17579/16735/PDDI%20CDS%20PSS%2002-15-2018%201.docx Contextualized potential drug-drug interaction clinical decision support PSS] |
Revision as of 21:18, 1 August 2018
HL7 TSC FMG Meeting Minutes Location: |
Date: 2018-08-01 Time: 4:00 PM U.S. Eastern | |
Chair: | Note taker(s): Anne W. |
Quorum = chair + 4 | yes/no | |||||
Co chairs | David Hay | Lloyd McKenzie | ||||
ex-officio | . | Wayne Kubick, CTO |
Members | Members | Members | Observers/Guests | ||||
Hans Buitendijk | Brian Postlethwaite | Paul Knapp | Anne W., scribe | ||||
Josh Mandel | John Moehrke | Brian Pech | |||||
Grahame Grieve | . |
Agenda
- Roll Call
- Agenda Check
- Minutes from 2018-07-18_FMG_concall
- Action items
- David to create tracker items for the QA that wasn't applied
- Grahame to put together something to describe a desired level of BR&R community engagement in order to own Substance
- Grahame to draft a process for approving technically breaking changes that are believed not to impact any implementations and submit for review by FMG, MnM and SGB
- VerificationResult: Brian to check with WG regarding the potential for splitting
- Anne to nudge TSC about what they want to do about expiring FMG positions
- TSC referred to SGB
- documenting/communicating policy on balloting/publishing as Normative (FMM5)
- Vetting unapproved resources for publication
- Review Items
- Contextualized potential drug-drug interaction clinical decision support PSS
- CDISC Lab Semantics in FHIR PSS
- Review of remaining tracker items
- Discussion Topics
- Reports
- Connectathon management (David/Brian)
- SGB –
- MnM –
- FMG Liaisons –
- Process management
- Ballot Planning
- Ballot content review and QA process FHIR QA Guidelines
- AOB (Any Other Business)
Minutes
Next Steps
Actions (Include Owner, Action Item, and due date) | |||
Next Meeting/Preliminary Agenda Items |
Back to FHIR_Management_Group
© 2018 Health Level Seven® International